Vancouver company co-founded by Pieter Cullis specializes in genetic medicine delivery platform
NanoVation Therapeutics, a Vancouver company co-founded by biotech magnate Pieter Cullis, has struck a partnership with Danish pharmaceutical company Novo Nordisk that could be worth up to $800 million.
The two companies will collaborate on the development of gene-editing therapies for certain rare genetic diseases.
Under terms of the deal, Novo Nordisk will get an exclusive license to…
Read More…